Leonurine hydrochloride-a new drug for the treatment of menopausal syndrome: Synthesis, estrogen-like effects and pharmacokinetics.

This research aimed to investigate the estrogen-like effects of Leonurine hydrochloride (Leo). First, we developed a total synthesis of Leo from 3,4,5-trimethoxy-benzoic acid and the structure was confirmed through 1H NMR and mass spectrometry (MS). Then the estrogenic activity of Leo in vitro and in vivo was studied. The proliferation and proliferation inhibitory effects of Leo on MCF-7 cells and MDA-MB-231 cells indicate that Leo exerts estrogen-like effects through estrogen receptor α (ERα) and estrogen receptor ß((ERß) in vitro. Uterotrophic assay in juvenile mice showed that Leo has an estrogen-like effect in vivo, as it can promote the development of the uterus of juvenile mice, increase its uterine coefficient and the size of the uterine cavity, as well as the increased number of uterine glands and the thickened uterine wall. For further research, cyclophosphamide (CTX) was used to establish a mouse model of ovarian function decline. Through this model, we found that Leo can restore the estrous cycle of mice, increase the number of primordial and primary follicles in the ovaries of mice, and regulate the disordered hypothalamic-pituitary-ovarian (HPOA) axis of mice. Finally, the pharmacokinetics of Leo was studied and oral bioavailability of Leo was calculated to be 2.21%. Leo was synthesized and the estrogen-like effect in vitro and in vivo was confirmed as well as its pharmacokinetics.

Synthesis, characterization, antidiabetic and antioxidative evaluation of a novel Zn(II)-gallic acid complex with multi-facet activity.

OBJECTIVES: This study was done to synthesize a novel Zn(II)-gallic acid complex with improved antidiabetic and antioxidative properties. METHODS: The complex was synthesized and characterized using Fourier Transform Infrared (FT-IR) and 1 H NMR. Cytotoxicity was evaluated using Chang liver cells and L6 myotubes. Radical scavenging and Fe3+ -reducing, as well as α-glucosidase, α-amylase and glycation inhibitory properties were measured. Glucose uptake was measured in L6 myotubes, while the complex was docked against glucose transporter type 4 (GLUT-4) and protein kinase B (PKB). KEY FINDINGS: Analysis showed that complexation occurred through a Zn(O4 ) coordination; thus, the complex acquired two moieties of gallic acid, which suggests why complexation increased the DPPH (IC50  = 48.2 µm) and ABTS (IC50  = 12.7 µm) scavenging and α-glucosidase inhibitory (IC50  = 58.5 µm) properties of gallic acid by several folds (5.5, 3.6 and 2.7 folds; IC50  = 8.79, 3.51 and 21.5 µm, respectively). Zn(II) conferred a potent dose-dependent glucose uptake activity (EC50  = 9.17 µm) on gallic acid, without reducing the viability of L6 myotubes and hepatocytes. Docking analysis showed the complex had stronger interaction with insulin signalling proteins (GLUT-4 and PKB) than its precursor. CONCLUSIONS: Data suggest that complexation of Zn(II) with gallic acid resulted in a complex with improved and multi-facet antioxidative and glycaemic control properties.

Synthesis and Comparative Structure-Activity Study of Carbohydrate-Based Phenolic Compounds as α-Glucosidase Inhibitors and Antioxidants.

Twenty-one natural and unnatural phenolic compounds containing a carbohydrate moiety were synthesized and their structure-activity relationship (SAR) was evaluated for α-glucosidase inhibition and antioxidative activity. Varying the position of the galloyl unit on the 1,5-anhydro-d-glucitol (1,5-AG) core resulted in changes in the α-glucosidase inhibitory activity and notably, particularly strong activity was demonstrated when the galloyl unit was present at the C-2 position. Furthermore, increasing the number of the galloyl units significantly affected the α-glucosidase inhibition, and 2,3,4,6-tetra-galloyl-1,5-AG (54) and 2,3,4,6-tetra-galloyl-d-glucopyranose (61) exhibited excellent activities, which were more than 13-fold higher than the α-glucosidase inhibitory activity of acertannin (37). Moreover, a comparative structure-activity study suggested that a hemiacetal hydroxyl functionality in the carbohydrate core and a biaryl bond of the 4,6-O-hexahydroxydiphenoyl (HHDP) group, which are components of ellagitannins including tellimagrandin I, are not necessary for the α-glucosidase inhibitory activity. Lastly, the antioxidant activity increased proportionally with the number of galloyl units.

Design and screening of syringic acid analogues as BAX activators-An in silico approach to discover "BH3 mimetics".

Although BAX, which is a molecular hit squad that incentive apoptosis was found to be an attractive emerging target for anticancer agents. The molecular mechanism of small molecules/peptides involved in the BAX activation was remain unknown. The present focus of the study is to identification and development of novel molecules which are precisely activates BAX mediated apoptosis. In this process we identified some syringic acid analogues associated with the BAX hydrophobic groove by a virtual-screen approach. Results from the docking studies revealed that, SA1, SA9, SA10, SA14 and SA21 analogues have shown good interaction with BAX trigger site, of which SA10 and SA14 bound specifically with Lys21 at α1 helix of BAX, a critical residue involved in BAX activation. All docking calculations of SA analogues were compared with clinically tested BH3 mimetics. In this entire in silico study, SA analogous have performed an ideal binding interactions with BAX compared to BH3 mimetics. Further, in silico point mutation of BAX-Lys21 to Glu21 resulted in structural change in BAX and showed reduced binding energy and hydrogen bond interactions of the selected ligands. Based on these findings, we propose that virtual screening and mutation analysis of BAX is found to be the critical advance method towards the discovery of novel anticancer therapeutics.

Discovery of Leonuri and therapeutical applications: From bench to bedside.

Despite several advances in percutaneous coronary intervention and the discovery of new drugs, the incidence of myocardial infarction and deaths due to cardiovascular diseases (CVD) has not decreased markedly in China. The quality of life is affected seriously, which further results in great social and family burden. Many drugs, from the century-old aspirin to the newly FDA-approved Byvalson, have been proven to be effective in the treatment and prevention of CVD. As clinically reported, those life-saving drugs still have their side effects in regards to the narrow therapeutic indexes influenced by individual genetic variations. Herba Leonuri, also known as Chinese Motherwort, which are naturally present in plants and traditionally are used for the uterotonic action, postpartum blood stasis, breast pain as well as other gynecological disorders in China for thousands of years. Since the last two decades, our group has reported leonurine, a unique alkaloid found in Herba Leonuri, exhibits various bioactivities such as antioxidant, anti-apoptotic effects, free radical scavenging and anti-inflammatory effects, in addition to improving micro-circulation. These bioactivities are related to the underlying mechanisms of ischemic heart diseases and cardiac fibrosis. Pharmacological studies have proven leonurine to be effective in treating CVD in various ways, particularly ischemic heart diseases. Besides the cardio protective effects, which are similar in the central nervous system, more specifically, inhibited mitochondrial reactive oxygen species production together with the restored mitochondrial function and redox state were observed in middle cerebral artery occlusion rats by leonurine treatment, which strongly reveals its neuroprotective effects and carries a therapeutic potential for recovery and prevention of stroke. Based on their mode of action, we propose that leonurine can be developed as drugs to treat ischemic heart diseases. Taking advantage of the most recent findings in pharmacological research including the effects of low toxicity and good pharmacokinetics characteristics, leonurine has a very attractive prospect of clinical application. Our recent promising pharmacological results may be able to eradicate the barrier hindering its sale on market. In sum, from bench to bedside is no longer a long way for leonurine.

Novel hamamelitannin analogues for the treatment of biofilm related MRSA infections-A scaffold hopping approach.

Antimicrobial research is increasingly being focused on the problem of resistance and biofilm formation. Hamamelitannin (HAM) was recently identified as an antimicrobial potentiator for conventional antibiotics towards Staphylococcus aureus. This paper describes the synthesis and biological evaluation of novel hamamelitannin analogues with alternative central scaffolds. Via a ligand-based approach, several interesting compounds with improved synthetic accessibility were identified as potentiators for vancomycin in the treatment of MRSA infections.

Identificación de ácidos polifenólicos en el extracto metanólico de las hojas de terminalia catappa Linn / Identification of polyphenolic acids in the methanolic extract from Terminalia catappa Linn leaves

INTRODUCCIÓN: diferentes extractos de Terminalia Catappa Linn. (Combretaceae) han demostrado de forma internacional, propiedades farmacológicas beneficiosas para la salud humana. Estas propiedades han sido atribuidas en lo fundamental a los polifenoles y glicósidos, encontrados en hojas, corteza y frutos. En Cuba esta especie es catalogada como una planta invasora y existen pocas investigaciones sobre su composición química y estudios farmacológicos. OBJETIVOS: identificar y cuantificar los ácidos polifenólicos presentes en el extracto metanólico de las hojas de T. catappa utilizándose la cromatografía de gases acoplada a espectrometría de masas. MÉTODOS: las hojas amarillo-rojizas fueron secadas, molidas, desgrasadas con hexano y y con posterioridad extraídas con metanol en un baño ultrasónico. El extracto se filtró y el disolvente se eliminó al vacío. El extracto seco se hidrolizó con ácido clorhídrico y se extrajo con acetato de etilo. Se determinó el rendimiento de extracción, las características organolépticas y los polifenoles totales mediante el método de Follin-Ciocalteu. La composición química del extracto hidrolizado se llevó a cabo por cromatografía de gases acoplada a espectrometría de masas, previa formación de los derivados trimetilsilil. RESULTADOS: se obtuvo un líquido de color pardo rojizo oscuro de olor característico. El contenido total de polifenoles fue 184,6 (mg Pirogalol/100 g Extracto). Se detectaron 37 compuestos por cromatografía de gases acoplada a espectrometría de masas en el extracto metanólico hidrolizado. Este extracto está compuesto de manera general por ácidos polifenólicos como el ácido gálico; ácido vanílico; ácido 3,4-dihidroxibenzoico; ácido 2,5-dihidroxi-benzoico y ácido 4- hidroxibenzoico. También se detectaron otros compuestos con elevados contenidos como ácido elágico y ácido levulínico. CONCLUSIONES: el extracto metanólico de hojas de T. catappa que crece en Cuba mostró un elevado contenido de ácidos polifenólicos, donde los ácidos gálico y elágico fueron los mayoritarios. La presencia de estos compuestos pudiera justificar las propiedades medicinales atribuidas a esta especie, a la vez que servirían de base para continuar con futuras pruebas farmacológicas que avalen sus usos con fines farmacéuticos.

INTRODUCTION: Different extracts of Terminalia Catappa Linn. (Combretaceae) internationally have shown pharmacological properties beneficial to human health. These properties have been largely attributed to polyphenols and their glycosides found in the leaves, bark and fruits. In Cuba this species is listed as an invasive plant and there is limited research on its chemical composition and pharmacological studies. OBJECTIVES: To identify and quantify the polyphenolic acids that could be present in the methanol extract of Terminalia catappa leaves using gas chromatography-mass spectrometry. METHODS: The yellow-red leaves were dried, ground, defatted with hexane and then extracted with methanol in an ultrasonic bath. The extract was filtered and the solvent removed under vacuum. The dry extract was hydrolyzed with hydrochloric acid and extracted with ethyl acetate. The extraction yield, the organoleptic characteristics and the total polyphenols by Follin-Ciocalteu method were determined. The chemical composition of the hydrolyzed extract was performed by gas chromatography-mass spectrometry after formation of trimethylsilyl derivatives. RESULTS: A dark reddish brown liquid with a characteristic odor was obtained. The total polyphenol content was 184.6 (mg Pyrogallol/100g extract). By mean of gas chromatography-mass spectrometry a total of 37 compounds were detected in the hydrolyzed methanol extract. This extract consists mainly of polyphenolic acids such as gallic acid; vanillic acid; 3,4-dihydroxybenzoic acid; 2,5-dihydroxybenzoic acid and 4- hydroxybenzoic acid. Other compounds with high content as ellagic acid and levulinic acid were also detected. CONCLUSIONS: The methanolic extract obtained from the leaves of Terminalia catappa growing in Cuba showed a high content of polyphenolic acids where gallic acid and ellagic predominated. The presence of these compounds could justify the medicinal properties attributed to this species, while providing the basis for further future pharmacological evidence to support its use for pharmaceutical purposes.

Identificación de ácidos polifenólicos en el extracto metanólico de las hojas de Terminalia catappa Linn / Identification of polyphenolic acids in the methanolic extract from Terminalia catappa Linn leaves

Introducción: diferentes extractos de Terminalia Catappa Linn. (Combretaceae) han demostrado de forma internacional, propiedades farmacológicas beneficiosas para la salud humana. Estas propiedades han sido atribuidas en lo fundamental a los polifenoles y glicósidos, encontrados en hojas, corteza y frutos. En Cuba esta especie es catalogada como una planta invasora y existen pocas investigaciones sobre su composición química y estudios farmacológicos. Objetivos: identificar y cuantificar los ácidos polifenólicos presentes en el extracto metanólico de las hojas de T. catappa utilizándose la cromatografía de gases acoplada a espectrometría de masas. Métodos: las hojas amarillo-rojizas fueron secadas, molidas, desgrasadas con hexano y y con posterioridad extraídas con metanol en un baño ultrasónico. El extracto se filtró y el disolvente se eliminó al vacío. El extracto seco se hidrolizó con ácido clorhídrico y se extrajo con acetato de etilo. Se determinó el rendimiento de extracción, las características organolépticas y los polifenoles totales mediante el método de Follin-Ciocalteu. La composición química del extracto hidrolizado se llevó a cabo por cromatografía de gases acoplada a espectrometría de masas, previa formación de los derivados trimetilsilil. Resultados: se obtuvo un líquido de color pardo rojizo oscuro de olor característico. El contenido total de polifenoles fue 184,6 (mg Pirogalol/100 g Extracto). Se detectaron 37 compuestos por cromatografía de gases acoplada a espectrometría de masas en el extracto metanólico..(AU)

Introduction: Different extracts of Terminalia Catappa Linn. (Combretaceae) internationally have shown pharmacological properties beneficial to human health. These properties have been largely attributed to polyphenols and their glycosides found in the leaves, bark and fruits. In Cuba this species is listed as an invasive plant and there is limited research on its chemical composition and pharmacological studies. Objectives: To identify and quantify the polyphenolic acids that could be present in the methanol extract of Terminalia catappa leaves using gas chromatography-mass spectrometry. Methods: The yellow-red leaves were dried, ground, defatted with hexane and then extracted with methanol in an ultrasonic bath. The extract was filtered and the solvent removed under vacuum. The dry extract was hydrolyzed with hydrochloric acid and extracted with ethyl acetate. The extraction yield, the organoleptic characteristics and the total polyphenols by Follin-Ciocalteu method were determined. The chemical composition of the hydrolyzed extract was performed by gas chromatography-mass spectrometry after formation of trimethylsilyl derivatives. Results: A dark reddish brown liquid with a characteristic odor was obtained. The total polyphenol content...(AU)

Identification of KMU-3, a novel derivative of gallic acid, as an inhibitor of adipogenesis.

Differentiation of preadipocyte, also called adipogenesis, leads to the phenotype of mature adipocyte. Excessive adipogenesis, however, is largely linked to the development of obesity. Herein we investigated a library of 53 novel chemicals, generated from a number of polyphenolic natural compounds, on adipogenesis. Strikingly, among the chemicals tested, KMU-3, a derivative of gallic acid, strongly suppressed lipid accumulation during the differentiation of 3T3-L1 preadipocytes into adipocytes. On mechanistic levels, KMU-3 inhibited expressions of CCAAT/enhancer-binding protein-α (C/EBP-α), peroxisome proliferator-activated receptor-γ (PPAR-γ), and fatty acid synthase (FAS) during adipocyte differentiation. Moreover, KMU-3 reduced expressions of adipokines, including retinol binding protein-4 (RBP-4), leptin, and regulated on activation, normal T cell expressed and secreted (RANTES) during adipocyte differentiation. Of further note, KMU-3 rapidly blocked the phosphorylation of signal transducer and activator of transcription-3 (STAT-3) during the early stage of adipogenesis. Importantly, pharmacological inhibition studies revealed that AG490, a JAK-2/STAT-3 inhibitor suppressed adipogenesis and STAT-3 phosphorylation, implying that early blockage of STAT-3 activity is crucial for the KMU-3-mediated anti-adipogenesis. These findings demonstrate firstly that KMU-3 inhibits adipogenesis by down-regulating STAT-3, PPAR-γ, C/EBP-α, and FAS. This work shows that KMU-3 is an inhibitor of adipogenesis and thus may have therapeutic potential against obesity.

Neuroprotection of a novel synthetic caffeic acid-syringic acid hybrid compound against experimentally induced transient cerebral ischemic damage.

We investigated effects of caffeic acid, syringic acid, and their synthesis on transient cerebral ischemic damage in the gerbil hippocampal CA1 region. In the 10 mg/kg caffeic acid-, syringic acid-, and 20 mg/kg syringic-treated ischemia groups, we did not find any significant neuroprotection in the ischemic hippocampal CA region. In the 20 mg/kg caffeic acid- and 10 mg/kg caffeic acid-syringic acid-treated ischemia groups, moderate neuroprotection was found in the hippocampal CA1 region. In the 20 mg/kg caffeic acid-syringic acid-treated ischemia group, a strong neuroprotective effect was found in the ischemic hippocampal CA1 region: about 89 % of hippocampal CA1 region pyramidal neurons survived. We also observed changes in glial cells (astrocytes and microglia) in the ischemic hippocampal CA1 region in all the groups. Among them, the distribution pattern of the glial cells was only in the 20 mg/kg caffeic acid-syringic acid-treated ischemia group similar to that in the sham group (control). In brief, 20 mg/kg caffeic acid-syringic acid showed a strong neuroprotective effect with an inhibition of glia activation in the hippocampal CA1 region induced by transient cerebral ischemia.

Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid.

The n-alkyl esters of gallic acid (CAS 13857-8) have a diverse range of uses as antioxidants in food, cosmetics and pharmaceutical industries. Pharmaceutical studies performed with these compounds have found that they have many therapeutic potentialities including anti-cancer, antiviral and antimicrobial properties. However, more interest has been devoted to their antioxidant activity due to the ability to scavenge and reduce reactive oxygen species (ROS) formation. In this study, gallic acid and 14 different alkyl gallates were tested. The cytotoxicity and anti-herpetic (HSV-1, KOS and 29-R strains) activity were studied by using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay and the cell viability by using the Trypan blue dye exclusion method. The genotoxicity was studied by the Comet assay and the antioxidant activity by using the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging and microsomal lipid peroxidation-inhibiting activities. The results showed that all the tested compounds have anti-herpetic activity at non cytotoxic concentrations with selectivity indices (SI = CC50/EC50) varying from 0.89 to 18.34, depending on the used HSV-1 strain. It was observed that all tested alkyl gallates showed some degree of genotoxicity, at the tested concentrations, except cetyl gallate, at 256.60 micromol/L (p <0.05, t-Student test), probably induced by ROS released by infected cells and/or by the alkyl gallates that were not antioxidants, at the tested concentrations, in which they demonstrated anti-herpetic activity. The hydroxyl groups can induce DNA damage due interactions with some metal ions, which are naturally present in the culture medium supplemented with fetal bovine serum, probably explaining the genotoxicity detected. However, the obtained results showed considerable antioxidant activity at smaller concentrations, when compared to quercetin which is considered as a reference drug due to its already described antioxidant potential: DPPH radical scavenging activity with IC50 values varying from 17 to 31 micromol/L; and microsomal lipid peroxidation-inhibiting activity with IC50 values varying from 21 to 59 micromol/L. It was observed that the presence of hydroxyl groups in these molecules is important for their pharmacological profile, but the length of the lateral carbonic chain does not have considerable influence.

Alkyl gallates, intensifiers of beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus.

We found that ethyl gallate purified from a dried pod of tara (Caesalpinia spinosa) intensified beta-lactam susceptibility in methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus (MRSA and MSSA strains, respectively). This compound and several known alkyl gallates were tested with MRSA and MSSA strains to gain new insights into their structural functions in relation to antimicrobial and beta-lactam susceptibility-intensifying activities. The maximum activity of alkyl gallates against MRSA and MSSA strains occurred at 1-nonyl and 1-decyl gallate, with an MIC at which 90% of the isolates tested were inhibited of 15.6 microg/ml. At concentrations lower than the MIC, alkyl gallates synergistically elevated the susceptibility of MRSA and MSSA strains to beta-lactam antibiotics. Such a synergistic activity of the alkyl gallates appears to be specific for beta-lactam antibiotics, because no significant changes were observed in the MICs of other classes of antibiotics examined in this study. The length of the alkyl chain was also associated with the modifying activity of the alkyl gallates, and the optimum length was C5 to C6. The present work clearly demonstrates that the length of the alkyl chain has a key role in the elevation of susceptibility to beta-lactam antibiotics.

Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation.

Kampo formulations are traditional herbal medications used in China and Japan for many centuries to treat diarrheal diseases such as cholera. Our studies were undertaken to identify and verify by chemical synthesis the active components that inhibited cholera toxin (CT), the virulence factor secreted by Vibrio cholerae, the causative agent of cholera. The Kampo formulation, Daio-kanzo-to, inhibited CT activities (i.e., ADP-ribosylation, Chinese hamster ovary cell elongation); in Daio-kanzo-to, Daio (Rhei rhizoma) was responsible for this effect. Among several components purified from Daio extract, rhubarb galloyl-tannin, a compound characterized by a polygallate structure, was the most effective. To define the active component, gallate analogues similar to rhubarb galloyl-tannin were synthesized. These gallate compounds inhibited all CT activities including ADP-ribosylation, elongation of Chinese hamster ovary cells, and importantly, fluid accumulation in ileal loops. Thus, Kampo formulations or their gallate components might be effective adjunctive therapy with oral rehydration solution for the severe diarrhea of cholera.

Methyl gallate, methyl-3,4,5-trihydroxybenzoate, is a potent and highly specific inhibitor of herpes simplex virus in vitro. I. Purification and characterization of methyl gallate from Sapium sebiferum.

A potent anti-herpetic compound was identified and purified to homogeneity from the leaves of Sapium sebiferum by plaque reduction assay using herpes simplex virus type 2. The chemical structure of the purified compound was determined by mass spectroscopy and proton and carbon-13 nuclear magnetic resonance as methyl gallate, methyl-3,4,5-trihydroxybenzoate. This is the first demonstration that methyl gallate is a potent anti-herpetic compound in vitro, present in high concentration in the leaves of S. sebiferum, a Chinese folk medicine for shingles.